Hybrid-APC Margin Ablation to Prevent Post EMR Adenoma Recurrence
Clinical trial NCT04015765 · COMPLETED
Trial details
- NCT number
- NCT04015765
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-26
- Primary completion
- 2024-12-13
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.